CYH

Business Context and Reporting Period

Company: Community Health Systems, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended June 30, 2002
Business Overview: The Company operates a network of hospitals providing inpatient and outpatient medical services. The period was characterized by significant acquisition activity, including three hospitals acquired in the first half of 2002, and the adoption of new accounting standards regarding goodwill.

Key Financial Metrics

Note: Total Debt calculated as Current maturities of long-term debt ($31,748) plus Long-term debt ($1,025,360) as of June 30, 2002.

Material Changes vs. Prior Period

• Revenue Growth: Net operating revenues increased 32.3% for the quarter and 33.1% for the six months compared to the prior year. Approximately 75% of the six-month increase was attributable to acquisitions, while same-hospital revenue grew 8.7%.
• Profitability: Net income for the six months more than doubled to $51.4 million from $20.5 million. This was driven by revenue growth, a $19.9 million decrease in interest expense, and the elimination of $14.1 million in goodwill amortization due to the adoption of SFAS No. 142.
• Expense Ratios: Operating expenses as a percentage of revenue increased from 81.1% to 83.1% for the six-month period, primarily due to lower initial margins at recently acquired hospitals. However, same-hospital operating expenses decreased to 80.8%.
• Acquisitions: The Company acquired three hospitals in the first half of 2002 (one in Q2, two in Q1) for a total consideration of approximately $82 million ($65 million cash, $17 million assumed liabilities).

Guidance, Outlook, and Risks

• Capital Resources: On July 16, 2002, the Company entered into a new $1.2 billion senior secured credit facility ($850 million term loan, $350 million revolver) to refinance existing debt and fund acquisitions. This transaction is expected to result in a $5.3 million after-tax extraordinary loss in Q3 2002 related to debt extinguishment costs.
• Capital Expenditures: The Company expects total capital expenditures of $102 million to $110 million for the full year 2002, including approximately $38 million for the construction of replacement hospitals required by purchase agreements.
• Regulatory Risks: The Company faces risks related to changes in Medicare and Medicaid reimbursement rates, which have historically increased less than inflation. There is also exposure to managed care negotiations and potential legislative healthcare reforms.
• Legal Proceedings: A class-action lawsuit was filed in July 2002 regarding a nurse at a Texas facility who was infected with HIV and allegedly stole narcotics. The Company believes the suit is without merit and intends to defend vigorously.
• Accounting Changes: The adoption of SFAS No. 142 eliminated goodwill amortization, increasing reported net income by $0.12 per share for the six months ended June 30, 2002.

Investor Verification Checklist

• Acquisition Integration: Verify the timeline for realizing cost synergies and margin improvements at the three hospitals acquired in 2002, which currently drag down overall EBITDA margins.
• Debt Refinancing Impact: Confirm the timing and magnitude of the $5.3 million extraordinary loss associated with the July 2002 credit facility refinancing in the upcoming Q3 report.
• Replacement Hospital Costs: Monitor progress and cost overruns on the $105 million obligation to construct three replacement hospitals by 2005.
• Reimbursement Rates: Assess the impact of the April 2002 changes to the Medicare outpatient prospective payment system on future revenue growth.
• Legal Exposure: Track the status of the "Jane Doe" class-action lawsuit regarding the HIV-infected nurse to evaluate potential liability.